Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Yкраїнський (UK)
Przejdź do strony domowej biblioteki Centralna Biblioteka Wojskowa Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaCentralna Biblioteka Wojskowa

Wyszukujesz frazę "Zaluska, K." wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    Additive suppression of tonic-clonic seizures in mice receiving the combination of carbamazepine, phenobarbital and valproate
    Autorzy:
    Zaluska, K.
    Marzeda, P.
    Bojar, H.
    Walczak, A.
    Chmielewski, J.
    Wroblewska-Luczka, P.
    Luszczki, J.J.
    Powiązania:
    https://bibliotekanauki.pl/articles/3303.pdf
    Data publikacji:
    2019
    Wydawca:
    Instytut Medycyny Wsi
    Źródło:
    Journal of Pre-Clinical and Clinical Research; 2019, 13, 2
    1898-2395
    Pojawia się w:
    Journal of Pre-Clinical and Clinical Research
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Synergy among oxcarbazepine, pregabalin and topiramate in the mouse maximal electroshockinduced seizure test – an isobolographic analysis
    Autorzy:
    Zaluska, K.
    Panasiuk-Poterek, A.N.
    Kondrad-Wrobel, M.W.
    Marzeda, P.
    Walczak, A.
    Gut-Lepiech, A.
    Wroblewska-Luczka, P.
    Luszczki, J.J.
    Powiązania:
    https://bibliotekanauki.pl/articles/3409.pdf
    Data publikacji:
    2018
    Wydawca:
    Instytut Medycyny Wsi
    Źródło:
    Journal of Pre-Clinical and Clinical Research; 2018, 12, 4
    1898-2395
    Pojawia się w:
    Journal of Pre-Clinical and Clinical Research
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Electrical bioimpedance in patients after ischemic stroke, a civilization disease
    Autorzy:
    Nalepa, D.
    Czrkowska, M.
    Załuska, W.
    Jakubowska, K.
    Chruściel, P.
    Powiązania:
    https://bibliotekanauki.pl/articles/2082979.pdf
    Data publikacji:
    2019
    Wydawca:
    Instytut Medycyny Wsi
    Tematy:
    cerebral stroke
    electrical bioimpedance
    hydration
    Opis:
    Introduction. Ischemic stroke is caused by artery blockage, resulting in damage to brain tissue. A significant factor in the further treatment of a patient is not only the time to reach a specialist centre, but also the state of hydration of the organism. Clinical situations involving the excess or deficiency of water can have extremely serious consequences for the functioning of the body and subsequent stroke-related disorders. One of the increasingly common methods of evaluating the composition of the human body is by electrical bioimpedance. Objective. The aim of the study was to assess the state of human body hydration measured by bioimpedance in patients with an early stage of ischemic stroke. Methods and materials. The examination involved 81 patients with ischemic stroke in the Neurology Department, Subdivision of Stroke Treatment at the Province Specialist Hospital in Lublin, Poland, in 2015. Measurement of the composition and outer and intracellular space of the human body by the Whole Body Bioimpedance (WBIA) method was performed using the Body Composition Monitor (BCM) (Fresenius Medical Care GmbH, Bad Homburg, Germany). Results. A group of patients were been examined with the use of the BIA apparatus three times: on the first, seventh, and tenth day of hospital stay, to determine the level of body hydration. Comparative analysis of data showed that on the first day of hospitalization all the measurements of electrical bioimpedance parameters in the patients were significantly different from those of the control group. In the case of TBW, ECW, ICW, the patients’ scores were significantly higher than those of the control group. Only with respect to the over-hydration index, the patients achieved a significantly lower score than the control group. Conclusions. Assessment of hydration status in patients with a diagnosed stroke indicates a slight dehydration in relation to the control group, but falling within the scope of normovolaemia, according to bioimpedance measurement standards.
    Źródło:
    Annals of Agricultural and Environmental Medicine; 2019, 26, 1; 46-50
    1232-1966
    Pojawia się w:
    Annals of Agricultural and Environmental Medicine
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Sudden cardiac arrest induced by hypoglycemia and hypokalemia in a chronic alcoholic patient
    Autorzy:
    Prystupa, A.
    Kucharska, K.
    Darbar, H.
    Parmar, N.
    Parmar, R.
    Zaluska, W.
    Mosiewicz, J.
    Powiązania:
    https://bibliotekanauki.pl/articles/3351.pdf
    Data publikacji:
    2010
    Wydawca:
    Instytut Medycyny Wsi
    Tematy:
    sudden cardiac arrest
    hypoglycemia
    hypokalemia
    chronic alcoholism
    patient
    sudden carsiac death
    cardiac disease
    Źródło:
    Journal of Pre-Clinical and Clinical Research; 2010, 04, 1
    1898-2395
    Pojawia się w:
    Journal of Pre-Clinical and Clinical Research
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Factors influencing serum chemerin and kallistatin concentrations in patients with alcohol-induced liver cirrhosis
    Autorzy:
    Prystupa, A.
    Kiciński, P.
    Luchowska-Kocot, D.
    Sak, J.
    Prystupa, T.K.
    Tan, Y.-H.
    Panasiuk, L.
    Załuska, W.
    Powiązania:
    https://bibliotekanauki.pl/articles/2082078.pdf
    Data publikacji:
    2018
    Wydawca:
    Instytut Medycyny Wsi
    Tematy:
    alcohol-induced liver cirrhosis
    chemerin
    kallistatin
    Opis:
    Introduction. In Poland, an increasing number of patients are hospitalized due to liver diseases. One of the common liver diseases is cirrhosis, which can be caused by alcohol, viral hepatitis, autoimmune processes and metabolic diseases. Materials and method. The study included 99 patients with alcoholic cirrhosis from the Lublin region of Eastern Poland. The control group consisted of 20 healthy individuals without liver disease who did not abuse alcohol. The concentrations of serum kallistatin and chemerin were determined using ELISA kits. Objective. The aim of the study is to evaluate serum levels of kallistatin and chemerin in patients with different stages of alcoholic liver cirrhosis. Results. The highest chemerin level was found in the control group – 182.6±80.4 ng/ml. In other stages of liver cirrhosis, the following levels were observed: 175.7±62.7 ng/ml in Child-Pugh stage A (Ch-P A), 150.2±59.7 ng/ml in Ch-P B and 110.3±73.6 ng/ml in Ch-P C. Significant differences in chemerin levels between controls and Ch-P C patients (p=0.01), as well as between the Ch-P A patients and Ch-P C patients (p=0.02), were demonstrated. The highest kallistatin level was demonstrated in the control group – 8.2±3.5 μg/ml. In other stages of liver cirrhosis, the following concentrations were found: 7.2±27 μg/ml in Ch-P A, 4.4±2.2 μg/ml in Ch-P B and 3.5±1.9 μg/ml in Ch-P C (Tab. 3). Statistically significant differences were observed between controls and Ch-P B patients (p<0.001), controls and Ch-P C patients (p<0.001), Ch-P A and Ch-P B patients (p=0.01), as well as Ch-P A and Ch-P C patients (<0.001). Conclusions. The levels of chemerin and kallistatin decrease with progression of liver damage during alcoholic liver cirrhosis. The impairment of its synthetic function leads to reductions in levels of the adipokines studied.
    Źródło:
    Annals of Agricultural and Environmental Medicine; 2019, 26, 1; 143-147
    1232-1966
    Pojawia się w:
    Annals of Agricultural and Environmental Medicine
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
    Tytuł:
    Afamin and adropin in patients with alcohol-induced liver cirrhosis
    Autorzy:
    Prystupa, A.
    Kiciński, P.
    Luchowska-Kocot, D.
    Sak, J.
    Prystupa, T.
    Chen, K.-H.
    Chen, Y.-H.
    Panasiuk, L.
    Załuska, W.
    Powiązania:
    https://bibliotekanauki.pl/articles/2081906.pdf
    Data publikacji:
    2018
    Wydawca:
    Instytut Medycyny Wsi
    Tematy:
    alcoholic liver cirrhosis
    Adropin
    Child-Pugh score
    afamin
    Opis:
    The aim of the study was to determine serum concentrations of afamin and adropin in patients with alcoholic liver cirrhosis and to define their correlation with the stage of disease. The study included 99 patients with alcoholic cirrhosis from the region of Lublin, (Eastern Poland). Liver cirrhosis was diagnosed based on clinical features, history of heavy alcohol consumption, laboratory tests and abdominal ultrasonography. The control group consisted of 20 healthy individuals without liver disease who did not abuse alcohol. The serum afamin and adropin concentrations were determined using ELISA kits. The concentration of afamin was found to be significantly lower in patients with compensated alcoholic liver cirrhosis, i.e. P-Ch B (85.1±40.6 μg/ml) and P-Ch C (56.4±32.3 μg/ml) individuals, compared to the control group (135.9±43.6 μg/ml); p-value was <0.01 and <0.001, respectively. As far as adropin is concerned, a reverse relationship was demonstrated: the highest concentration was found in patients with P-Ch C (11.7±5.7 ng/ml) cirrhosis. Furthermore, the above concentration was significantly higher compared to patients with P-Ch A cirrhosis (7.2±2.8 ng/ml; p<0.05) and controls (7.5±2.6 ng/ml; p<0.05). The concentration of afamin decreases with the severity of alcoholic liver cirrhosis, which most likely results from impaired hepatic synthesis. Otherwise, the higher the stage of disease according to the Child-Pugh score, the higher the concentration of adropin.
    Źródło:
    Annals of Agricultural and Environmental Medicine; 2018, 25, 3; 527-531
    1232-1966
    Pojawia się w:
    Annals of Agricultural and Environmental Medicine
    Dostawca treści:
    Biblioteka Nauki
    Artykuł
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies